Notice of Open Public Hearing
| Published date | 28 April 2020 |
| Citation | 85 FR 23602 |
| Record Number | 2020-09002 |
| Section | Notices |
| Court | U.s.-china Economic And Security Review Commission |
Federal Register, Volume 85 Issue 82 (Tuesday, April 28, 2020)
[Federal Register Volume 85, Number 82 (Tuesday, April 28, 2020)]
[Notices]
[Pages 23602-23603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09002]
=======================================================================
-----------------------------------------------------------------------
U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION
Notice of Open Public Hearing
AGENCY: U.S.-China Economic and Security Review Commission.
ACTION: Notice of open public hearing.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given of the following hearing of the U.S.-
China Economic and Security Review Commission.
The Commission is mandated by Congress to investigate, assess, and
report to Congress annually on ``the national security implications of
the economic relationship between the United States and the People's
Republic of China.'' Pursuant to this mandate, the Commission will hold
a virtual public hearing in Washington, DC on May 7, 2020 on ``China's
Evolving Healthcare Ecosystem: Challenges and Opportunities.''
DATES: The hearing is scheduled for Thursday, May 7, 2020, at 9:30 a.m.
ADDRESSES: This hearing will be held online, with panelists and
Commissioners participating via videoconference. Members of the public
will be able to view a live webcast via the Commission's website at
www.uscc.gov. Please check the Commission's website for possible
[[Page 23603]]
changes to the hearing schedule. Reservations are not required to
attend the hearing.
FOR FURTHER INFORMATION CONTACT: Any member of the public seeking
further information concerning the hearing should contact Jameson
Cunningham, 444 North Capitol Street NW, Suite 602, Washington, DC
20001; telephone: 202-624-1496, or via email at [email protected].
Reservations are not required to attend the hearing.
ADA Accessibility: For questions about the accessibility of the
event or to request an accommodation, please contact Jameson Cunningham
at 202-624-1496, or via email at [email protected]. Requests for an
accommodation should be made as soon as possible, and at least five
business days prior to the event.
SUPPLEMENTARY INFORMATION:
Background: This hearing will examine new developments in China's
healthcare system, the challenges these pose to continued U.S.
leadership in the medical sciences, as well as the opportunities they
potentially create for U.S. researchers and companies. The first panel
reviews China's domestic healthcare infrastructure, Beijing's ambitions
for digital healthcare technologies, and China's public health
emergency preparedness both before and after the emergence of the
COVID-19 pandemic. The second panel will investigate linkages between
the United States and Chinese healthcare ecosystems, with a particular
emphasis on market access and data sharing, technological competition,
and the benefits and risks of research cooperation.
The hearing will be co-chaired by Chairman Robin Cleveland and
Commissioner Thea Lee. Any interested party may file a written
statement by May 7, 2020 by transmitting to the contact above. A
portion of the hearing will include a question and answer period
between the Commissioners and the witnesses.
Authority: Congress created the U.S.-China Economic and Security
Review Commission in 2000 in the National Defense Authorization Act
(Pub. L. 106-398), as amended by Division P of the Consolidated
Appropriations Resolution, 2003 (Pub. L. 108-7), as amended by Public
Law 109-108 (November 22, 2005), as amended by Public Law 113-291
(December 19, 2014).
Dated: April 23, 2020.
Daniel W. Peck,
Executive Director, U.S.-China Economic and Security Review Commission.
[FR Doc. 2020-09002 Filed 4-27-20; 8:45 am]
BILLING CODE 1137-00-P
